Content area
Furthermore, it would cut the cost and morbidity associated with antirejection medications required in conventional implantology. [...]it might help solve the present shortage of suitable organs for transplantation. Perry's reliance on legal terminology and case law epitomizes the tendency of most Institutional Review Boards (IRBs) to focus far too much attention on whether the informed consent form details all of the risks, the nondisclosure of which could result in a lawsuit, and far too little attention on whether the final document is likely to be comprehended by its probable reader. While a few IRBs may permit research that fails to adequately disclose risks, a vast majority are obsessed with avoiding lawsuits and the scrutiny of federal regulators. Because of this, the challenges facing researchers are seldom knowing whether their consent form meets the legal requirements.